Derek T. Chalmers, President & CEO at Cara Therapeutics, Inc. (CARA), sold 12,156 shares at $15.30 ($186K) on 2020-12-30, disclosed to the SEC on 2020-12-30.
Open-market sale of $186k CARA by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.30 | 6,078 | $93K | 50.0% |
| 2 | $15.30 | 6,078 | $93K | 50.0% |
| Total | $15.30 avg | 12,156 | $186K | 100% |
| Filing → |
| CARA | SELL | 2021-03-08 | $112K | — | Filing → |
| CARA | SELL | 2021-02-25 | $453K | — | Filing → |
| CARA | SELL | 2020-12-29 | $80K | — | Filing → |